Literature DB >> 28343872

Orbital decompression for thyroid eye disease.

Daniel B Rootman1.   

Abstract

The literature regarding orbital decompression for thyroid eye disease is vast, spanning multiple specialty areas including neurosurgery, head and neck, maxillofacial, and ophthalmic plastic surgery. Although techniques have advanced considerably over the more than 100 years during which this procedure has been performed, the 4 major approaches remain: transorbital, transcranial, transantral, and transnasal. The explosion in literature related to orbital decompression has mostly involved minor technical variations on broader surgical themes. The purpose of this review is to organize the major approaches in terms of bony anatomy and to contextualize variation in transdisciplinary techniques within a common conceptualization.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  balanced decompression; dysthyroid optic neuropathy; fat decompression; lateral decompression; medial decompression; orbital decompression; surgical technique; thyroid eye disease

Mesh:

Year:  2017        PMID: 28343872     DOI: 10.1016/j.survophthal.2017.03.007

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  16 in total

Review 1.  Therapeutic difference between orbital decompression and glucocorticoids administration as the first-line treatment for dysthyroid optic neuropathy: a systematic review.

Authors:  Ming-Na Xu; Zhao-Qi Pan; Yun-Hai Tu; He-Qing Tao; Ke-Si Shi; Wen-Can Wu
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

2.  Combined Surgical Approaches In and Around the Orbit.

Authors:  S Tonya Stefko
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-04

3.  Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.

Authors:  Robbie S R Woods; Qistina Pilson; Natallia Kharytaniuk; Lorraine Cassidy; Rizwana Khan; Conrad V I Timon
Journal:  Ir J Med Sci       Date:  2019-06-16       Impact factor: 1.568

4.  The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy.

Authors:  Yun Wen; Jian-Hua Yan
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

5.  Endoscopic orbital fat decompression for the management of proptosis in Grave's orbitopathy using a laryngeal skimmer blade.

Authors:  David S Curragh; Dinesh Selva
Journal:  Eye (Lond)       Date:  2019-07-08       Impact factor: 3.775

6.  Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.

Authors:  Sandra Rezar-Dreindl; Andrea Papp; Arnulf Baumann; Thomas Neumayer; Katharina Eibenberger; Eva Stifter; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-22       Impact factor: 3.535

7.  MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.

Authors:  Sun Young Jang; Min Kyung Chae; Joon H Lee; Eun Jig Lee; Jin Sook Yoon
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

8.  Position and size of the sphenoid door jamb in the lateral orbital wall for the orbital decompression.

Authors:  Kang-Jae Shin; Shin-Hyo Lee; Tae-Jun Ha; Hyun Jin Shin; Ki-Seok Koh; Wu-Chul Song; Doo-Jin Paik
Journal:  Anat Cell Biol       Date:  2019-09-26

Review 9.  Multidisciplinary approach to orbital decompression. A review.

Authors:  Claudio Parrilla; Dario Antonio Mele; Silvia Gelli; Lorenzo Zelano; Francesco Bussu; Mario Rigante; Gustavo Savino; Emanuele Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

Review 10.  Application of lateral tarsoconjunctival flap to correct ocular complications of Madelung's disease: A case report and literature review.

Authors:  Lung-Chi Lee; Tsu-Heng Weng; Ke-Hao Huang; Hsin-Ting Lin; Chang-Min Liang; Ming-Cheng Tai; Jiann-Torng Chen; Ke-Hung Chien
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.